Adverse Events in Placebo Arms of Cancer Trials

JOHANNES E. WOLFF; BIRTE J. WOLFF; MARCEAL M. THIELEN; HOLGER HAUCH

doi:10.21873/anticanres.15761

Article Information

vol. 42 no. 6 2805-2812

DOI

https://doi.org/10.21873/anticanres.15761

PMID

35641292

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received March 6, 2022
Revision received March 31, 2022
Accepted April 12, 2022
Published online May 31, 2022.

Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

JOHANNES E. WOLFF1 ⇑,
BIRTE J. WOLFF2,
MARCEAL M. THIELEN1 and
HOLGER HAUCH3

¹AbbVie Inc, North Chicago, IL, U.S.A.;
²Swedish Covenant Hospital Department of Gynecology, Chicago, IL, U.S.A.;
³Pediatric Hematology and Oncology, University Children’s Hospital Giessen, Hesse, Germany

Correspondence to: Dr. med. habil. Johannes E. Wolff, MD, Ph.D., 1709 Napa Suwe Ln, Wauconda, IL 60084, U.S.A. Tel: +1 2242216093, Fax: +1 8479380660, e-mail: johannesewolff{at}gmail.com

View Full Text